CoChat

Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer’s Disease

Padhi, Dikshaa, Govindaraju, Thimmaiah · 2022 · Journal of Medicinal Chemistry

The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.

Abstract

The heterogeneity and complex nature of Alzheimer's disease (AD) is attributed to several genetic risk factors and molecular culprits. The slow pace and increasing failure rate of conventional drug discovery has led to the exploration of complementary strategies based on repurposing approved drugs to treat AD. Drug repurposing (DR) is a cost-effective, low-risk, and efficient approach for identifying novel therapeutic candidates for AD treatment. Similarly, hybrid drug design through the integration of distinct pharmacophores from known or failed drugs and natural products is an interesting strategy to target the multifactorial nature of AD. In this Perspective, we discuss the potential of DR and highlight promising drug candidates that can be advanced for clinical trials, backed by a detailed discussion on their plausible mechanisms of action. Our article fosters research on the hidden potential of DR and hybrid drug design with the goal of unravelling new drugs and targets to tackle AD.

Overview

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.2c00335

Cites

143 of 143 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 143 references

Research works printed but not linked: 5

  1. Samanta S., 2022, Alzheimer’s Disease: Recent Findings in Pathophysiology, Diagnostic and Therapeutic Modalities, 1
  2. 10.1039/c5cc05264e · DOI · Paper page
  3. 10.1021/acschemneuro.8b00033 · DOI · Paper page
  4. 10.1172/jci0215451 · doi:10.1172/jci0215451 · Paper page
  5. Wang S., 2016, J. Alzheimers Parkinsonism Dement., 1, 007

Cited by

See all 49

Metadata

Authors
Padhi, D., & Govindaraju, T.
Affiliations
Jawaharlal Nehru Centre for Advanced Scientific Research (IN)
Corresponding author
Govindaraju, Thimmaiah
Venue
Journal of Medicinal Chemistry
Published
2022-05-13
Volume
65
Issue
10
Pages
7088-7105
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W4280528552
Cited by
47
References
143
Citations by year
2026: 7 · 2025: 7 · 2024: 17 · 2023: 13 · 2022: 3
FWCI
1.38
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Science and Engineering Research Board (CRG/2020/004594)
  • Department of Science and Technology, Ministry of Science and Technology (DST/SJF/CSA-02/2015-2016, IFCPAR/CEFIPRA-62T10-3)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Keywords
Alzheimer's disease, drug repurposing, hybrid drug design, mechanism of action, natural products, complex diseases, clinical trial candidates
MeSH terms
Alzheimer Disease, Humans, Drug Discovery, Drug Repositioning

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer’s Disease. https://app.cochat.ai/papers/10.1021/acs.jmedchem.2c00335
The paper
Padhi, D., & Govindaraju, T. (2022). Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer’s Disease. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c00335

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.